このエントリーをはてなブックマークに追加


ID 68974
FullText URL
fulltext.pdf 1.45 MB
Author
Takeuchi-Hatanaka, Kazu Department of Periodontics and Endodontics, Okayama University Hospital
Ito, Masahiro Department of Periodontics and Endodontics, Okayama University Hospital
Hayashi, Yoshihiro Department of Periodontics and Endodontics, Okayama University Hospital
Maruyama, Hiroe Department of Periodontics and Endodontics, Okayama University Hospital
Kono, Hiroyuki Department of Periodontics and Endodontics, Okayama University Hospital
Shinoda-Ito, Yuki Department of Pathophysiology–Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Omori, Kazuhiro Department of Pathophysiology–Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Takashiba, Shogo Department of Pathophysiology–Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Abstract
Objectives Propolis possesses antibacterial, anti-inflammatory, and antioxidant properties. While its application in oral care has garnered significant attention, evidence supporting its effectiveness against periodontal bacteria is limited. This study used a randomized double-blind protocol to assess the safety and efficacy of toothpaste containing propolis compared to a placebo in patients undergoing supportive periodontal therapy (SPT).
Materials and methods Thirty-two participants in SPT were randomized into two groups: toothpaste containing 2.5% ethanol-extracted propolis (EEP) and a placebo without EEP. Participants brushed twice daily for four weeks, and clinical parameters, bacterial counts, and salivary characteristics were assessed before and after the intervention.
Results The propolis group showed a significant reduction in periodontal pocket depth (P = 0.006), with a mean depth of 3.80 mm compared to 4.35 mm in the placebo group. Bleeding on probing was significantly reduced in both groups (P = 0.032 in the propolis group and 0.0498 in the placebo group), but did not differ between groups. Total bacterial and Porphyromonas gingivalis (P. gingivalis) counts did not differ significantly between the groups; however, the number of patients with decreased P. gingivalis was slightly larger than those in the placebo group (not significant). Additionally, saliva acidity decreased significantly in the propolis group (P = 0.041), suggesting a shift toward a less pathogenic oral environment. No adverse events were observed.
Conclusion These findings suggest that propolis may contribute to stabilizing periodontal disease during supportive periodontal therapy by modulating salivary acidity.
Clinical relevance Periodontal pocket depth and the rate of bleeding on probing are reduced, along with decreased saliva acidity. Meanwhile, the levels of P. gingivalis in the periodontal pockets remain low. Propolis-dentifrice may help alleviate gingival inflammation during SPT.
Clinical trial registration Registered in the University Hospital Medical Information Network Clinical Trial Registry (ID: UMIN000029554).
Keywords
Propolis
Toothpaste
Periodontitis
Periodontal pocket
Saliva
Randomized controlled trial
Note
The version of record of this article, first published in Clinical Oral Investigations, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00784-025-06456-5
Published Date
2025-07-09
Publication Title
Clinical Oral Investigations
Volume
volume29
Issue
issue8
Publisher
Springer Science and Business Media LLC
Start Page
379
ISSN
1436-3771
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© The Author(s) 2025
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1007/s00784-025-06456-5
License
http://creativecommons.org/licenses/by/4.0/
Citation
Takeuchi-Hatanaka, K., Ito, M., Hayashi, Y. et al. Clinical and microbiological effects of a propolis toothpaste in patients with periodontitis under supportive periodontal therapy: a randomized double-blind clinical trial. Clin Oral Invest 29, 379 (2025). https://doi.org/10.1007/s00784-025-06456-5
助成情報
( 国立大学法人岡山大学 / Okayama University )
( アピ株式会社 / API Co., Ltd. )